MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for Primary Immunodeficiency

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Primary Immunodeficiency protocol — in the EU, from €3,000–€8,000.

For Primary Immunodeficiency, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Primary Immunodeficiency. Compare them on the Primary Immunodeficiency overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

European-grade cell therapy, without European prices.

GMP-certified regenerative medicine in the heart of the EU — from €3,000–8,000, a fraction of US or German pricing. Personalised protocols for international patients from 50+ countries.

Free medical review